This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2005 Mar;95(4):485-90.

doi: 10.1111/j.1464-410X.2005.05325.x.

Molecular pathways in bladder cancer: part 1

Richard T Bryan¹, Syed A Hussain, Nicholas D James, Janusz A Jankowski, D Michael A Wallace

Affiliations

PMID: 15705065
DOI: 10.1111/j.1464-410X.2005.05325.x

Review

Molecular pathways in bladder cancer: part 1

Richard T Bryan et al. BJU Int. 2005 Mar.

. 2005 Mar;95(4):485-90.

doi: 10.1111/j.1464-410X.2005.05325.x.

Authors

Richard T Bryan¹, Syed A Hussain, Nicholas D James, Janusz A Jankowski, D Michael A Wallace

Affiliation

¹ The Epithelial Laboratory, Division of Medical Sciences, The Queen Elizabeth Hospital, Birmingham, UK. etb@dsl.pipex.com

PMID: 15705065
DOI: 10.1111/j.1464-410X.2005.05325.x

No abstract available

PubMed Disclaimer

Similar articles

Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C, Klasmeyer K, Bojar H, Schulz WA, Ackermann R, Grimm MO. Kramer C, et al. Cancer. 2007 May 15;109(10):2016-24. doi: 10.1002/cncr.22627. Cancer. 2007. PMID: 17394193
p53 and treatment of bladder cancer.
Cote RJ, Esrig D, Groshen S, Jones PA, Skinner DG. Cote RJ, et al. Nature. 1997 Jan 9;385(6612):123-5. doi: 10.1038/385123b0. Nature. 1997. PMID: 8990112 Clinical Trial. No abstract available.
In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall.
Olbert PJ, Schrader AJ, Simon C, Dalpke A, Barth P, Hofmann R, Hegele A. Olbert PJ, et al. Anticancer Res. 2009 Jun;29(6):2067-76. Anticancer Res. 2009. PMID: 19528466
Molecular pathways in bladder cancer: part 2.
Bryan RT, Hussain SA, James ND, Jankowski JA, Wallace DM. Bryan RT, et al. BJU Int. 2005 Mar;95(4):491-6. doi: 10.1111/j.1464-410X.2005.05326.x. BJU Int. 2005. PMID: 15705066 Review. No abstract available.
Molecular pathology of low malignant bladder transitional cell carcinoma: a current perspective.
Wang HT, Chang JW. Wang HT, et al. Histol Histopathol. 2005 Jan;20(1):147-53. doi: 10.14670/HH-20.147. Histol Histopathol. 2005. PMID: 15578434 Review.

See all similar articles

Cited by

Effect of NAT2 gene polymorphism on bladder cancer risk in Slovak population.
Klimčáková L, Habalová V, Sivoňová M, Nagy V, Šalagovič J, Židzik J. Klimčáková L, et al. Mol Biol Rep. 2011 Feb;38(2):1287-93. doi: 10.1007/s11033-010-0228-6. Epub 2010 Jun 22. Mol Biol Rep. 2011. PMID: 20568013
YWHAZ amplification/overexpression defines aggressive bladder cancer and contributes to chemo-/radio-resistance by suppressing caspase-mediated apoptosis.
Yu CC, Li CF, Chen IH, Lai MT, Lin ZJ, Korla PK, Chai CY, Ko G, Chen CM, Hwang T, Lee SC, Sheu JJ. Yu CC, et al. J Pathol. 2019 Aug;248(4):476-487. doi: 10.1002/path.5274. Epub 2019 Apr 29. J Pathol. 2019. PMID: 30945298 Free PMC article.
Significance of CDKN2A gene A148T variant in patients with bladder cancer.
Borkowska E, Jędrzejczyk A, Kruk A, Pietrusiński M, Traczyk M, Rożniecki M, Kałużewski B. Borkowska E, et al. Cent European J Urol. 2011;64(3):168-74. doi: 10.5173/ceju.2011.03.art17. Epub 2011 Sep 6. Cent European J Urol. 2011. PMID: 24578887 Free PMC article.
Tropomyosins: Potential Biomarkers for Urothelial Bladder Cancer.
Humayun-Zakaria N, Arnold R, Goel A, Ward D, Savill S, Bryan RT. Humayun-Zakaria N, et al. Int J Mol Sci. 2019 Mar 4;20(5):1102. doi: 10.3390/ijms20051102. Int J Mol Sci. 2019. PMID: 30836651 Free PMC article. Review.
Personalized therapy for urothelial cancer: review of the clinical evidence.
Guancial EA, Chowdhury D, Rosenberg JE. Guancial EA, et al. Clin Investig (Lond). 2011 Apr;1(4):546-555. doi: 10.4155/cli.11.26. Clin Investig (Lond). 2011. PMID: 22754656 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information